EKSO - Ekso Bionics Holdings Inc Stock Price, Fair Value and News

$0.69-0.03 (-4.17%)

Market Closed

Max Portfolio Pct.

Check

Valuation

Check

Stock Quality:

Max Portfolio Pct.

Check

Valuation

Check

EKSO Price Action

Last 7 days

-8%

Last 30 days

-33.0%

Last 90 days

-35.5%

Trailing 12 Months

-55.5%

EKSO RSI Chart

EKSO Valuation

Market Cap

15.2M

Price/Earnings (Trailing)

-1.36

Price/Sales (Trailing)

0.86

Price/Free Cashflow

-1.51

EKSO Price/Sales (Trailing)

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Risk

Balance Sheet

Momentum

Funds Popularity

Insider Trading

EKSO Fundamentals

EKSO Revenue

Revenue (TTM)

17.7M

Rev. Growth (Yr)

-10.38%

Rev. Growth (Qtr)

-16.59%

EKSO Earnings

Earnings (TTM)

-11.1M

Earnings Growth (Yr)

38.42%

Earnings Growth (Qtr)

14.24%

EKSO Profitability

Return on Equity

-74.86%

Return on Assets

-38.11%

Free Cashflow Yield

-66.25%

EKSO Investor Care

Shares Dilution (1Y)

54.54%

Revenue & Growth

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs

Net sales

Year	Q1	Q2	Q3	Q4
2024	17.9M	18.2M	17.7M	0
2023	14.4M	15.8M	17.1M	18.3M
2022	11.9M	13.0M	13.3M	12.8M
2021	8.2M	8.1M	8.3M	11.2M
2020	11.8M	10.8M	10.3M	7.8M
2019	12.4M	12.7M	13.5M	13.9M
2018	8.4M	9.5M	10.5M	11.3M
2017	7.2M	7.5M	7.5M	7.4M
2016	15.5M	14.9M	13.6M	14.2M
2015	6.0M	6.9M	8.2M	8.7M
2014	3.7M	3.9M	4.6M	5.3M
2013	3.4M	4.4M	5.2M	3.3M
2012	0	0	0	2.7M

Get all data in R, Python etc through our Historical Stock Data APIs

About Ekso Bionics Holdings Inc

Ekso Bionics Holdings, Inc. designs, develops, sells, and rents exoskeleton products in the Americas, Europe, the Middle east, Africa, the Asia Pacific, and internationally. It operates in two segments, EksoHealth and EksoWorks. The EksoHealth segment designs, engineers, manufactures, and markets exoskeletons for applications in the medical markets. The EksoWorks segment designs, engineers, manufactures, and markets exoskeleton devices to allow able-bodied users to perform difficult repetitive work for extended periods. The company also provides EksoNR, a wearable bionic suit and rehabilitation device that assists physical therapists and physicians to treat patients with acquired brain injury, stroke, and spinal cord injury; Ekso Indego Therap, an adjustable and lower-limb powered exoskeleton; and Ekso Indego Personal, a powered lower limb orthosis. It has a license agreement with Lockheed Martin Corporation. The company was incorporated in 2005 and is headquartered in San Rafael, California.

CEO	Mr. Scott G. Davis
WEBSITE	eksobionics.com
SECTOR	Healthcare
INDUSTRY	Medical Instruments & Supplies
EMPLOYEES	72

Ekso Bionics Holdings Inc Frequently Asked Questions

What is the ticker symbol for Ekso Bionics Holdings Inc? What does EKSO stand for in stocks?

EKSO is the stock ticker symbol of Ekso Bionics Holdings Inc. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Ekso Bionics Holdings Inc (EKSO)?

As of Fri Nov 22 2024, market cap of Ekso Bionics Holdings Inc is 15.18 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of EKSO stock?

You can check EKSO's fair value in chart for subscribers.

Is Ekso Bionics Holdings Inc a good stock to buy?

The fair value guage provides a quick view whether EKSO is over valued or under valued. Whether Ekso Bionics Holdings Inc is cheap or expensive depends on the assumptions which impact Ekso Bionics Holdings Inc's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for EKSO.

What is Ekso Bionics Holdings Inc's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Fri Nov 22 2024, EKSO's PE ratio (Price to Earnings) is -1.36 and Price to Sales (PS) ratio is 0.86. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. EKSO PE ratio will change depending on the future growth rate expectations of investors.

What is 5 year return on Ekso Bionics Holdings Inc's stock?

In the past 10 years, Ekso Bionics Holdings Inc has provided -0.426 (multiply by 100 for percentage) rate of return.